Recombinant human erythropoietin (CHO Cell), Harbin Pharmaceutical Group Bioengineering
重组人促红素(CHO细胞) (哈药集团生物工程有限公司)
Report date: 2022/01/24 17:42:10
Base Information
Drug NameRecombinant human erythropoietin (CHO Cell), Harbin Pharmaceutical Group Bioengineering
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2005/10/19
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHarbin Pharmaceutical Group Holding Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHarbin Pharmaceutical Group Holding Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A